{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:51:17Z","timestamp":1791521477905,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.metabol.2026.156761","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:35:34Z","timestamp":1788849334000},"page":"156761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevention of type 2 diabetes in India and China"],"prefix":"10.1016","volume":"184","author":[{"given":"Ranjit","family":"Unnikrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit Mohan","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156761_bb0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2025"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41572-025-00635-0","article-title":"Prediabetes","volume":"11","author":"Unnikrishnan","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.metabol.2026.156761_bb0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00125-023-06085-1","article-title":"Feasibility of prevention of type 2 diabetes in low- and middle-income countries","volume":"67","author":"Kengne","year":"2024","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.metabol.2026.156761_bb0020","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dbi25-0006","article-title":"Pathobiology of prediabetes: understanding and interrupting progressive dysglycemia and associated complications","volume":"74","author":"Dagogo-Jack","year":"2025","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.metabol.2026.156761_bb0025","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.metabol.2026.156761_bb0030","doi-asserted-by":"crossref","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","article-title":"Diabetes in China part 1: epidemiology and risk factors","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"issue":"7","key":"10.1016\/j.metabol.2026.156761_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","volume":"11","author":"Anjana","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"10.1016\/j.metabol.2026.156761_bb0040","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2026.156761_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s13410-023-01204-5","article-title":"Secular trends in the prevalence of diabetes and prediabetes among the rural population of South India","volume":"43","author":"Lakshmi","year":"2023","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"8","key":"10.1016\/j.metabol.2026.156761_bb0050","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/dc14-2814","article-title":"Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES)","volume":"38","author":"Anjana","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.metabol.2026.156761_bb0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156761_bb0060","doi-asserted-by":"crossref","first-page":"e1675","DOI":"10.1016\/S2214-109X(19)30451-6","article-title":"National Burden Estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data","volume":"7","author":"Menon","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.metabol.2026.156761_bb0065","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the global burden of disease study 1990\u20132016","volume":"6","author":"Prabhakaran","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.metabol.2026.156761_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004079","article-title":"Urban-rural differences in hypertension prevalence in low-income and middle-income countries, 1990\u20132020: a systematic review and meta-analysis","volume":"19","author":"Ranzani","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.metabol.2026.156761_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01530-0","article-title":"Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.metabol.2026.156761_bb0080","article-title":"Geographical variations in cardiovascular health in China: a nationwide population-based survey of 74,726 adults","volume":"3","author":"Zhang","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"10.1016\/j.metabol.2026.156761_bb0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2026.156761_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"10.1016\/j.metabol.2026.156761_bb0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.metabol.2026.156761_bb0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.metabol.2026.156761_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3680","article-title":"Effects of treatment with glucagon-like peptide-1 receptor agonist on prediabetes with overweight\/obesity: a systematic review and meta-analysis","volume":"39","author":"Wang","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.metabol.2026.156761_bb0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.soard.2025.01.008","article-title":"Bariatric surgery significantly reduces progression from prediabetes to diabetes compared with the general population: 15-year single-institution data","volume":"21","author":"Pina","year":"2025","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1016\/j.metabol.2026.156761_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian diabetes prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.metabol.2026.156761_bb0120","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2337\/dc07-0150","article-title":"Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP)","volume":"30","author":"Ramachandran","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2026.156761_bb0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00125-009-1315-x","article-title":"Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)","volume":"52","author":"Ramachandran","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcd.2011.04.005","article-title":"A model of translational research for diabetes prevention in low and middle-income countries: the Diabetes Community Lifestyle Improvement Program (D-CLIP) trial","volume":"6","author":"Weber","year":"2012","journal-title":"Prim Care Diabetes"},{"issue":"10","key":"10.1016\/j.metabol.2026.156761_bb0135","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12889-017-4986-0","article-title":"Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP)","volume":"17","author":"Mathews","year":"2018","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.metabol.2026.156761_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002575","article-title":"A peer-support lifestyle intervention for preventing type 2 diabetes in India: a cluster-randomized controlled trial of the Kerala Diabetes Prevention Program","volume":"15","author":"Thankappan","year":"2018","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.metabol.2026.156761_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S2213-8587(23)00132-8","volume":"11","author":"Zhang","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2026.156761_bb0155","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.2337\/dc19-2046","article-title":"Impact of Acarbose on incident diabetes and regression to normoglycemia in people with coronary heart disease and impaired glucose tolerance: insights from the ACE trial","volume":"43","author":"Gerstein","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156761_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2971382","article-title":"A randomized controlled clinical trial of lifestyle intervention and pioglitazone for normalization of glucose status in Chinese with prediabetes","volume":"2022","author":"Luo","year":"2022","journal-title":"J Diabetes Res"},{"issue":"2","key":"10.1016\/j.metabol.2026.156761_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S2213-8587(25)00360-2","article-title":"Defining prediabetes remission as a distinct prevention endpoint","volume":"14","author":"Birkenfeld","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156761_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2213-8587(25)00295-5","article-title":"Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the diabetes prevention program outcome study and the DaQing Diabetes Prevention Outcome study","volume":"14","author":"Arreola","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156761_bb0175","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2337\/dc23-0696","article-title":"Effect of conventional lifestyle interventions on type 2 diabetes incidence by glucose-defined prediabetes phenotype: an individual participant data meta-analysis of randomized controlled trials","volume":"46","author":"Sathish","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.metabol.2026.156761_bb0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11892-025-01581-7","article-title":"The unique ethnicity-specific aspects of burden, pathogenesis and management of prediabetes: insights from Africa","volume":"25","author":"Kunyiha","year":"2025","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2026.156761_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156430","article-title":"Lifestyle intervention is more effective in high 1-hour post-load glucose than in prediabetes for restoring \u03b2-cell function, reducing ectopic fat, and preventing type 2 diabetes","volume":"174","author":"Wang","year":"2026","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.metabol.2026.156761_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/dci25-0054","article-title":"Beyond glucose\u2014rethinking prediabetes for precision prevention","volume":"49","author":"Wagner","year":"2025","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.metabol.2026.156761_bb0205","article-title":"Data-driven subgroups of prediabetes and the associations with outcomes in Chinese adults","volume":"4","author":"Zheng","year":"2023","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156761_bb0210","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ajcnut.2024.08.031","article-title":"Efficacy of lifestyle weight loss interventions on regression to normoglycemia and progression to type 2 diabetes in individuals with prediabetes: a systematic review and pairwise and dose-response meta-analyses","volume":"120","author":"Jayedi","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2230-8210.107825","article-title":"Expanding role of the Madras diabetes research foundation - Indian diabetes risk score in clinical practice","volume":"17","author":"Mohan","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2026.156761_bb0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/dc08-0403","article-title":"Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India","volume":"32","author":"Somannavar","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156761_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.diabres.2016.04.050","article-title":"Glucose tolerance status of Asian Indian women with gestational diabetes at 6 weeks to 1 year postpartum (WINGS-7)","volume":"117","author":"Bhavadharini","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/dme.13102","article-title":"Conversion of gestational diabetes mellitus to future type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort","volume":"34","author":"Gupta","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2026.156761_bb0235","article-title":"Multigenerational diabetes mellitus","volume":"14","author":"Thornton","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.metabol.2026.156761_bb0240","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metabol.2026.156761_bb0245","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2337\/diacare.26.9.2518","article-title":"Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes","volume":"26","author":"Diabetes Prevention Program Research Group","year":"2003","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.metabol.2026.156761_bb0250","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7539","article-title":"Cost-effectiveness of a stepwise approach vs standard care for diabetes prevention in India","volume":"3","author":"Islek","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01704-9","article-title":"Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: trial-based analysis of the Kerala diabetes prevention program","volume":"18","author":"Sathish","year":"2020","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.metabol.2026.156761_bb0260","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2213-8587(19)30001-4","article-title":"Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial","volume":"7","author":"Fottrell","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156761_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242962","article-title":"Cost-effectiveness of the Da Qing diabetes prevention program: a modelling study","volume":"15","author":"Hu","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.metabol.2026.156761_bb0270","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.1016\/S2214-109X(23)00348-0","article-title":"Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data","volume":"11","author":"Rahim","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.metabol.2026.156761_bb0275","doi-asserted-by":"crossref","first-page":"e1232","DOI":"10.1016\/S2214-109X(24)00150-5","article-title":"National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022: a pooled analysis of 507 population-based surveys with 5\u00b77 million participants","volume":"12","author":"Strain","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5868-11-26","article-title":"Physical activity and inactivity patterns in India - results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]","volume":"11","author":"Anjana","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"1","key":"10.1016\/j.metabol.2026.156761_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diabres.2014.09.053","article-title":"Exercise patterns and behaviour in Asian Indians: data from the baseline survey of the diabetes community lifestyle improvement program (D-CLIP)","volume":"107","author":"Anjana","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.metabol.2026.156761_bb0290","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/19322968251332925","article-title":"A novel high-intensity short interval dance intervention (THANDAV) for non-communicable disease prevention tailored to Asian Indian adolescent girls","volume":"19","author":"Anjana","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156761_bb0295","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/s41591-025-03949-4","article-title":"Dietary profiles and associated metabolic risk factors in India from the ICMR-INDIAB survey-21","volume":"31","author":"Anjana","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2026.156761_bb0300","doi-asserted-by":"crossref","DOI":"10.2337\/dc22-0627","article-title":"Macronutrient recommendations for remission and prevention of diabetes in Asian Indians based on a data-driven optimization model: the ICMR-INDIAB National Study","author":"Anjana","year":"2022","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.metabol.2026.156761_bb0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(13)70067-6","article-title":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","volume":"1","author":"Ramachandran","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2026.156761_bb0310","article-title":"Effectiveness of mobile health applications for cardiometabolic risk reduction in urban and rural India: a pilot, randomized controlled study","author":"Ranjani","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"23","key":"10.1016\/j.metabol.2026.156761_bb0315","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2025.19563","article-title":"An AI-powered lifestyle intervention vs human coaching in the diabetes prevention program: a randomized clinical trial","volume":"334","author":"Mathioudakis","year":"2025","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.metabol.2026.156761_bb0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrendo.2012.46","article-title":"Preventing diabetes mellitus in developing countries","volume":"8","author":"Echouffo-Tcheugui","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156761_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003964","article-title":"Evaluation of an adapted version of the diabetes prevention program for low- and middle-income countries: a cluster randomized trial to evaluate \u201clifestyle Africa\u201d in South Africa","volume":"19","author":"Catley","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.metabol.2026.156761_bb0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2019.08.022","article-title":"Grenada heart project-community health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): a randomized control peer group-based lifestyle intervention","volume":"220","author":"Latina","year":"2020","journal-title":"Am Heart J"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952600274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952600274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:43:54Z","timestamp":1791521034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952600274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":66,"alternative-id":["S002604952600274X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156761","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of type 2 diabetes in India and China","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156761"}}